Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 11:38 am Sale |
2024-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
BRATTON DOUGLAS K | 10,077,434 11.100% |
-40,000 (-0.40%) |
Filing History |
| 2024-02-13 4:27 pm Sale |
2023-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 5,750,882 4.200% |
-1,250,000 (-17.85%) |
Filing History |
| 2023-05-03 4:36 pm Purchase |
2023-04-30 | 13D | Midwest Holding Inc. MDWT |
BRATTON DOUGLAS K | 445,171 11.900% |
445,171 (New Position) |
Filing History |
| 2023-02-13 4:14 pm Sale |
2022-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 7,000,882 5.200% |
-844,307 (-10.76%) |
Filing History |
| 2022-12-21 5:02 pm Sale |
2022-12-14 | 13G | Altitude Acquisition Corp. ALTU |
BRATTON DOUGLAS K | 0 0.000% |
-70,573 (Position Closed) |
Filing History |
| 2022-12-13 5:01 pm Purchase |
2022-12-07 | 13G | Altitude Acquisition Corp. ALTU |
BRATTON DOUGLAS K | 70,573 4.200% |
70,573 (New Position) |
Filing History |
| 2022-11-18 11:01 am Unchanged |
2022-11-08 | 13G | Royalty Management Holding Corporation RMCO |
BRATTON DOUGLAS K | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 2:37 pm Sale |
2021-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 7,845,189 6.400% |
-4,503,595 (-36.47%) |
Filing History |
| 2022-02-11 4:03 pm Sale |
2021-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
BRATTON DOUGLAS K | 10,117,434 25.200% |
-1,494,320 (-12.87%) |
Filing History |
| 2021-02-12 4:19 pm Sale |
2020-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 12,348,784 10.300% |
-8,066,751 (-39.51%) |
Filing History |
| 2021-02-09 3:19 pm Purchase |
2020-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
BRATTON DOUGLAS K | 11,611,754 34.500% |
26,700 (+0.23%) |
Filing History |
| 2020-05-04 2:27 pm Purchase |
2020-04-24 | 13D | Midwest Holding Inc. MDWT |
BRATTON DOUGLAS K | 444,444 16.300% |
444,444 (New Position) |
Filing History |